All posts tagged "CYDY"
-
464BiotechAtea Failure Leaves Todos Medical (TOMDF) Last Man Standing in Oral Antivirals
The big news circulating this week was of Atea Pharmaceuticals’ (NASDAQ: AVIR) COVID-19 antiviral clinical trial failure, which instantly plummeted the stock...
-
1.8KBiotechModerna’s (MRNA) Bloated Market Cap & mRNA Vaccine Thesis Under Fire
Shares of Moderna (NASDAQ: MRNA) recently spiked over $400, giving the mRNA vaccine maker a market cap of about $200 billion, greater...
-
2.0KBiotechCytoDyn (CYDY) Shorts Throttle Up Bashing Ahead of August Super News Cycle
Short attack timed to capitalize on consolidation and thin trading The Oregonian misquotes and twists statements taken out of context SEC case...
-
2.2K2BiotechCytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)
CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial in metastatic triple negative breast cancer...
-
3.9KBiotechEnzolytics (ENZC) Working With Intel (INTC)
Intel whitepaper highlights case study on Enzolytics COVID-19 and HIV potential for neutralization of both viruses. Bear case is nothing but FUD....
-
2.0KBiotechCytoDyn FDA Letter is Old News – International Still Progressing
CytoDyn Inc (OTCMKTS: CYDY) shareholders got a real gut check yesterday as the STAT writer Adam Feuerstein sent out a tweet at...
-
2.2KBiotechCytoDyn’s Adjust Course to Emphasize Philippine EUA and Long Haulers
Many CytoDyn Inc. (OTCMKTS: CYDY) shareholders have been waiting impatiently for an EUA from the US FDA and a BLA in HIV. ...
-
2.4KBiotechCytoDyn Doubles Down on Revenue and EUA Strategy with Philippines Announcement
CytoDyn Inc. (OTCMKTS: CYDY) announced yesterday that it shipped 28 doses of leronlimab under Compassionate Special Permit (CSP) to one hospital in...
-
2.8KMomentum & GrowthOTC Markets Update: CYDY EEENF ENZC OPTI
We are starting to see some stability in the OTC Markets. The last few weeks have been hard on many OTC traders...
-
2.0KBiotechCOVID Stocks Popping in Sympathy with Positive Humanigen Top Line Data
Humanigen Inc. (NASDAQ: HGEN) released excellent news that their drug lenzilumab improved survival without the need for invasive mechanical ventila...
